Monoclonal gammopathy of undetermined significance (MGUS) is present in 3% of people more 70 years of ag e. It is our hypothesis that although both multiple myeloma (MM) and MGUS are characterized by the presence of abnormal bone marrow (BM) plasma cells, they are biologically different. The mechanisms of why some patients transform from MGUS to MM are poorly understood. It is clear from our initial studies that abnormal plasma cells can circulate and proliferate in the peripheral blood (PB) of patients with MM. However, their remains debate as to whether the disease is propagated at the plasma cell level versus a precursor B-cell. This proposal will involve the collaboration of two laboratories to examine cells from split-samples of the PB and BM of patients with MM and MGUS to gain a better understanding of how frequently circulating plasma cells and clonally-related cells are found in these diseases and the immunologic and molecular characteristics of these cells. PBMNC from patients with MGUS and MM will be analyzed for plasma cells and precursor B-cells by two-color immunofluorescence microscopy, multiparameter DNA content flow cytometry (FC), and three-color immunophenotyping by FC. An allele-specific oligonucleotide (ASO) will be used in a sensitive and tumor-specific polymerase chain reaction (PCR) technique developed in our laboratory to identify and quantitate malignant plasma cells and clonally-related cells. Cells sorted by various size, immunophenotypic, and DNA content parameters will be examined with the ASO-PCR technique to learn the specific characteristics of the malignant clone. Cells will also be sorted by FC into CD38+ and CD38- fractions and examined by reverse transcript PCR to identify clonally related transcripts that are derived from early B-cell precursors.
We aim to learn 1) Do precursor cells or plasma cells circulate in the pB of patients with MGUS? 2) Can clonal cells be demonstrated in the pB of patients with MM or MGUS when no plasma cells are found thus providing evidence for circulating precursor cells? 3) If precursor cells are found, what is their molecular and immunophenotype? and 4) Can monoclonal plasma cells be grown in stromal cell cultures or in SCID mice from sorted cell populations? These results will better define the role of the PB cells in producing and maintaining malignant cells. The study of both MGUS and MM patients provides an opportunity to better understand the similarities and differences in circulating cells found in these two diseases and their role in disease progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA062242-04S1
Application #
6269640
Study Section
Project Start
1997-08-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Lwin, S T; Fowler, J A; Drake, M T et al. (2017) A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo. Mol Cancer 16:49
Gonsalves, W I; Rajkumar, S V; Dispenzieri, A et al. (2017) Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression. Leukemia 31:130-135
Mullikin, Trey C; Rajkumar, S Vincent; Dispenzieri, Angela et al. (2016) Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol 91:473-5
Gonsalves, Wilson I; Timm, Michael M; Rajkumar, S Vincent et al. (2016) The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Leuk Res 44:32-9
Kaufman, Gregory P; Dispenzieri, Angela; Gertz, Morie A et al. (2015) Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis. Am J Hematol 90:181-6
Gonsalves, W I; Leung, N; Rajkumar, S V et al. (2015) Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer J 5:e296
Cesarman-Maus, Gabriela; Braggio, Esteban; Lome-Maldonado, Carmen et al. (2014) Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin. Thromb Res 133:606-9
Landgren, O; Graubard, B I; Katzmann, J A et al. (2014) Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia 28:1537-42
Kumar, S K; Dispenzieri, A; Lacy, M Q et al. (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122-8
Gonsalves, Wilson I; Rajkumar, S Vincent; Go, Ronald S et al. (2014) Trends in survival of patients with primary plasma cell leukemia: a population-based analysis. Blood 124:907-12

Showing the most recent 10 out of 365 publications